Reversible transient blood-brain barrier disruption appears to be reasonably simple to achieve and fairly safe. One can project exploitation of such a delivery technique not only to the use of cytoreductive drugs for neoplasms in the brain but also for enhanced delivery of antibiotics in central nervous system infections or enzymes in circumstances of inborn errors of metabolism.
|Original language||English (US)|
|Number of pages||3|
|Journal||Annals of internal medicine|
|Issue number||1 I|
|State||Published - Jan 1 1980|
ASJC Scopus subject areas
- Internal Medicine